394 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by TriaGen Wealth Management LLC

TriaGen Wealth Management LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 394 shares of the biotechnology company’s stock, valued at approximately $234,000.

Other large investors have also recently modified their holdings of the company. Quent Capital LLC increased its holdings in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the period. Prestige Wealth Management Group LLC grew its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at about $40,000. Brooklyn Investment Group bought a new position in shares of Axon Enterprise during the third quarter worth about $41,000. Finally, Planning Capital Management Corp lifted its stake in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $652.18 on Friday. The stock has a market cap of $49.73 billion, a P/E ratio of 168.52, a P/E/G ratio of 6.41 and a beta of 1.04. The business’s fifty day moving average is $619.63 and its 200 day moving average is $481.39. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,545 shares of company stock valued at $30,721,337. Corporate insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of a number of recent analyst reports. Robert W. Baird increased their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Finally, TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $524.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.